Home > > > > > Report Detail

Global Prophylactic Hepatitis B Virus Vaccines Market Growth (Status and Outlook) 2022-2028

Publisher Name :
Date: 25-Jan-2022
No. of pages: 89

As the global economy mends, the 2021 growth of Prophylactic Hepatitis B Virus Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global Prophylactic Hepatitis B Virus Vaccines market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Prophylactic Hepatitis B Virus Vaccines market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Prophylactic Hepatitis B Virus Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Prophylactic Hepatitis B Virus Vaccines market, reaching US$ million by the year 2028. As for the Europe Prophylactic Hepatitis B Virus Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Prophylactic Hepatitis B Virus Vaccines players cover Merck, Sanofi Pasteur, Novartis, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Prophylactic Hepatitis B Virus Vaccines market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

- Hepatitis B

- Liver Cirrhosis

- Hepatocellular Carcinoma

- Liver Failure

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

- Hospitals

- Clinics

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

- Merck

- Sanofi Pasteur

- Novartis

- Pfizer

- GlaxoSmithKline

Global Prophylactic Hepatitis B Virus Vaccines Market Growth (Status and Outlook) 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prophylactic Hepatitis B Virus Vaccines Market Size 2017-2028
2.1.2 Prophylactic Hepatitis B Virus Vaccines Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Prophylactic Hepatitis B Virus Vaccines Segment by Type
2.2.1 Hepatitis B
2.2.2 Liver Cirrhosis
2.2.3 Hepatocellular Carcinoma
2.2.4 Liver Failure
2.3 Prophylactic Hepatitis B Virus Vaccines Market Size by Type
2.3.1 Prophylactic Hepatitis B Virus Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Type (2017-2022)
2.4 Prophylactic Hepatitis B Virus Vaccines Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Prophylactic Hepatitis B Virus Vaccines Market Size by Application
2.5.1 Prophylactic Hepatitis B Virus Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Application (2017-2022)
3 Prophylactic Hepatitis B Virus Vaccines Market Size by Player
3.1 Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Players
3.1.1 Global Prophylactic Hepatitis B Virus Vaccines Revenue by Players (2020-2022)
3.1.2 Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Players (2020-2022)
3.2 Global Prophylactic Hepatitis B Virus Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Prophylactic Hepatitis B Virus Vaccines by Regions
4.1 Prophylactic Hepatitis B Virus Vaccines Market Size by Regions (2017-2022)
4.2 Americas Prophylactic Hepatitis B Virus Vaccines Market Size Growth (2017-2022)
4.3 APAC Prophylactic Hepatitis B Virus Vaccines Market Size Growth (2017-2022)
4.4 Europe Prophylactic Hepatitis B Virus Vaccines Market Size Growth (2017-2022)
4.5 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size Growth (2017-2022)
5 Americas
5.1 Americas Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2017-2022)
5.2 Americas Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2017-2022)
5.3 Americas Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prophylactic Hepatitis B Virus Vaccines Market Size by Region (2017-2022)
6.2 APAC Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2017-2022)
6.3 APAC Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Prophylactic Hepatitis B Virus Vaccines by Country (2017-2022)
7.2 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2017-2022)
7.3 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines by Region (2017-2022)
8.2 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2017-2022)
8.3 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.1 Global Prophylactic Hepatitis B Virus Vaccines Forecast by Regions (2023-2028)
10.1.1 Global Prophylactic Hepatitis B Virus Vaccines Forecast by Regions (2023-2028)
10.1.2 Americas Prophylactic Hepatitis B Virus Vaccines Forecast
10.1.3 APAC Prophylactic Hepatitis B Virus Vaccines Forecast
10.1.4 Europe Prophylactic Hepatitis B Virus Vaccines Forecast
10.1.5 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Forecast
10.2 Americas Prophylactic Hepatitis B Virus Vaccines Forecast by Country (2023-2028)
10.2.1 United States Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.2.2 Canada Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.2.3 Mexico Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.2.4 Brazil Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.3 APAC Prophylactic Hepatitis B Virus Vaccines Forecast by Region (2023-2028)
10.3.1 China Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.3.2 Japan Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.3.3 Korea Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.3.4 Southeast Asia Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.3.5 India Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.3.6 Australia Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.4 Europe Prophylactic Hepatitis B Virus Vaccines Forecast by Country (2023-2028)
10.4.1 Germany Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.4.2 France Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.4.3 UK Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.4.4 Italy Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.4.5 Russia Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.5 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Forecast by Region (2023-2028)
10.5.1 Egypt Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.5.2 South Africa Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.5.3 Israel Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.5.4 Turkey Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.5.5 GCC Countries Prophylactic Hepatitis B Virus Vaccines Market Forecast
10.6 Global Prophylactic Hepatitis B Virus Vaccines Forecast by Type (2023-2028)
10.7 Global Prophylactic Hepatitis B Virus Vaccines Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Prophylactic Hepatitis B Virus Vaccines Product Offered
11.1.3 Merck Prophylactic Hepatitis B Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Sanofi Pasteur
11.2.1 Sanofi Pasteur Company Information
11.2.2 Sanofi Pasteur Prophylactic Hepatitis B Virus Vaccines Product Offered
11.2.3 Sanofi Pasteur Prophylactic Hepatitis B Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Sanofi Pasteur Main Business Overview
11.2.5 Sanofi Pasteur Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Prophylactic Hepatitis B Virus Vaccines Product Offered
11.3.3 Novartis Prophylactic Hepatitis B Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Prophylactic Hepatitis B Virus Vaccines Product Offered
11.4.3 Pfizer Prophylactic Hepatitis B Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Prophylactic Hepatitis B Virus Vaccines Product Offered
11.5.3 GlaxoSmithKline Prophylactic Hepatitis B Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Prophylactic Hepatitis B Virus Vaccines Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Hepatitis B
Table 3. Major Players of Liver Cirrhosis
Table 4. Major Players of Hepatocellular Carcinoma
Table 5. Major Players of Liver Failure
Table 6. Prophylactic Hepatitis B Virus Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Type (2017-2022)
Table 9. Prophylactic Hepatitis B Virus Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Application (2017-2022)
Table 12. Global Prophylactic Hepatitis B Virus Vaccines Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Player (2020-2022)
Table 14. Prophylactic Hepatitis B Virus Vaccines Key Players Head office and Products Offered
Table 15. Prophylactic Hepatitis B Virus Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Regions (2017-2022)
Table 20. Americas Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Country (2017-2022)
Table 22. Americas Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Type (2017-2022)
Table 24. Americas Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Application (2017-2022)
Table 26. APAC Prophylactic Hepatitis B Virus Vaccines Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Region (2017-2022)
Table 28. APAC Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Type (2017-2022)
Table 30. APAC Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Application (2017-2022)
Table 32. Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Country (2017-2022)
Table 34. Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Type (2017-2022)
Table 36. Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Prophylactic Hepatitis B Virus Vaccines
Table 45. Key Market Challenges & Risks of Prophylactic Hepatitis B Virus Vaccines
Table 46. Key Industry Trends of Prophylactic Hepatitis B Virus Vaccines
Table 47. Global Prophylactic Hepatitis B Virus Vaccines Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Prophylactic Hepatitis B Virus Vaccines Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Prophylactic Hepatitis B Virus Vaccines Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Prophylactic Hepatitis B Virus Vaccines Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Prophylactic Hepatitis B Virus Vaccines Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Prophylactic Hepatitis B Virus Vaccines Market Size Market Share Forecast by Application (2023-2028)
Table 53. Merck Details, Company Type, Prophylactic Hepatitis B Virus Vaccines Area Served and Its Competitors
Table 54. Merck Prophylactic Hepatitis B Virus Vaccines Product Offered
Table 55. Merck Prophylactic Hepatitis B Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Merck Main Business
Table 57. Merck Latest Developments
Table 58. Sanofi Pasteur Details, Company Type, Prophylactic Hepatitis B Virus Vaccines Area Served and Its Competitors
Table 59. Sanofi Pasteur Prophylactic Hepatitis B Virus Vaccines Product Offered
Table 60. Sanofi Pasteur Main Business
Table 61. Sanofi Pasteur Prophylactic Hepatitis B Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Sanofi Pasteur Latest Developments
Table 63. Novartis Details, Company Type, Prophylactic Hepatitis B Virus Vaccines Area Served and Its Competitors
Table 64. Novartis Prophylactic Hepatitis B Virus Vaccines Product Offered
Table 65. Novartis Main Business
Table 66. Novartis Prophylactic Hepatitis B Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Novartis Latest Developments
Table 68. Pfizer Details, Company Type, Prophylactic Hepatitis B Virus Vaccines Area Served and Its Competitors
Table 69. Pfizer Prophylactic Hepatitis B Virus Vaccines Product Offered
Table 70. Pfizer Main Business
Table 71. Pfizer Prophylactic Hepatitis B Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Pfizer Latest Developments
Table 73. GlaxoSmithKline Details, Company Type, Prophylactic Hepatitis B Virus Vaccines Area Served and Its Competitors
Table 74. GlaxoSmithKline Prophylactic Hepatitis B Virus Vaccines Product Offered
Table 75. GlaxoSmithKline Main Business
Table 76. GlaxoSmithKline Prophylactic Hepatitis B Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. GlaxoSmithKline Latest Developments
List of Figures
Figure 1. Prophylactic Hepatitis B Virus Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prophylactic Hepatitis B Virus Vaccines Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Type in 2021
Figure 7. Prophylactic Hepatitis B Virus Vaccines in Hospitals
Figure 8. Global Prophylactic Hepatitis B Virus Vaccines Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Prophylactic Hepatitis B Virus Vaccines in Clinics
Figure 10. Global Prophylactic Hepatitis B Virus Vaccines Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Global Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Application in 2021
Figure 12. Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Player in 2021
Figure 13. Global Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Prophylactic Hepatitis B Virus Vaccines Market Size 2017-2022 ($ Millions)
Figure 15. APAC Prophylactic Hepatitis B Virus Vaccines Market Size 2017-2022 ($ Millions)
Figure 16. Europe Prophylactic Hepatitis B Virus Vaccines Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size 2017-2022 ($ Millions)
Figure 18. Americas Prophylactic Hepatitis B Virus Vaccines Value Market Share by Country in 2021
Figure 19. Americas Prophylactic Hepatitis B Virus Vaccines Consumption Market Share by Type in 2021
Figure 20. Americas Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Application in 2021
Figure 21. United States Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Region in 2021
Figure 26. APAC Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Application in 2021
Figure 27. China Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Country in 2021
Figure 34. Europe Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Type in 2021
Figure 35. Europe Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Application in 2021
Figure 36. Germany Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size Market Share by Application in 2021
Figure 44. Egypt Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Prophylactic Hepatitis B Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 50. APAC Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 51. Europe Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 53. United States Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 54. Canada Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 57. China Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 58. Japan Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 59. Korea Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 61. India Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 62. Australia Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 63. Germany Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 64. France Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 65. UK Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 66. Italy Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 67. Russia Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 68. Spain Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 71. Israel Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Prophylactic Hepatitis B Virus Vaccines Market Size 2023-2028 ($ Millions)
  • Global Hepatitis A Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 89
    According to our LPI (LP Information) latest study, the global Hepatitis A Vaccine market size was valued at US$ 690.5 million in 2023. With growing demand in downstream market, the Hepatitis A Vaccine is forecast to a readjusted size of US$ 810.9 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Hepatitis A Vaccine market. Hepatitis A Vaccine are expected to show stable growth in the future market. However, produc......
  • Global Human Hepatitis B Immunoglobulin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 127
    Market Overview of Global Human Hepatitis B Immunoglobulin market: According to our latest research, the global Human Hepatitis B Immunoglobulin market looks promising in the next 5 years. As of 2022, the global Human Hepatitis B Immunoglobulin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensiv......
  • Global Hepatitis A Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 85
    According to our (Global Info Research) latest study, the global Hepatitis A Vaccine market size was valued at USD 726.3 million in 2023 and is forecast to a readjusted size of USD 842.5 million by 2030 with a CAGR of 2.1% during review period. Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currentl......
  • Global Hepatitis A Vaccine Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117
    Report Overview: Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 ye......
  • Global Thymosin a1 Professional Survey Report 2023, Forecast to 2028
    Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 103
    Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......
  • Global Thymosin a1 Market Research Report 2023, Forecast to 2028
    Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 136
    Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......
  • Global Hepatitis B Immune Globulin Market Research Report 2023
    Published: 06-Nov-2023        Price: US 2900 Onwards        Pages: 85
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hepatitis B Immune Globulin market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - ADMA Biologics - Bio Products Laboratory - Grifols - Biotest AG - CSL Behring - FFF Enterprises - Cleveland Clinic Seg......
  • Global Sofosbuvir Market Research Report 2023
    Published: 31-Oct-2023        Price: US 2900 Onwards        Pages: 94
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sofosbuvir market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Teva Pharmaceutical Industries Ltd - DONG BANG FUTURE TECH & LIFE CO., LTD - Beaukev Pharma International Pvt.Ltd - DEAFARMA - Tecoland - Anhui HaiKang Pha......
  • Global Hepatitis A Vaccine Market Insights, Forecast to 2029
    Published: 22-Sep-2023        Price: US 4900 Onwards        Pages: 97
    Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs